buthionine sulfoximine has been researched along with Colonic Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (25.81) | 18.7374 |
| 1990's | 13 (41.94) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 4 (12.90) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Collin, A; Kohan, R; Picotto, G; Tolosa de Talamoni, N | 1 |
| Ariga, T; Hasegawa, I; Hosono, T; Hosono-Fukao, T; Iitsuka, Y; Inada, K; Seki, T; Tanaka, R; Yamada, H | 1 |
| Alonso-Varona, A; Caramés, M; García-Alonso, I; Palomares, T | 2 |
| Iyamu, EW | 1 |
| Cai, DQ; Kim, DH; Kim, SK; Lee, KJ; Qi, XF; Shim, KY; Teng, YC; Yoon, YS | 1 |
| Cuevas, EP; Díaz-Laviada, I; Fernández-Moreno, MD; Gisbert, JP; Guijarro, LG; Hernández-Breijo, B; Monserrat, J; Ramírez-Rubio, S; Román, ID; Vara, D | 1 |
| Armstrong, JS; Ming, SH; Moore, PK; Nam, OC; Rose, P; Whiteman, M | 1 |
| Albino, AP; Komninou, D; Richie, JP | 1 |
| Chow, S; Hedley, DW | 1 |
| Berger, NA; Berger, SJ; Gosky, D; Willson, JK; Zborowska, E | 1 |
| Lee, JH; Naito, M; Tsuruo, T | 1 |
| Begg, AC; Los, G; Oldenburg, J; Pinedo, HM; Ruevekamp, M; Schornagel, JH; van Vugt, MJ | 1 |
| Balasubramanian, KA; Benard, O | 1 |
| Dimitriadis, KA; Geromichalos, GD; Kortsaris, AH; Kouretas, D; Papazisis, KT; Sivridis, E; Tsekreli, OK | 1 |
| Borud, O; Huseby, NE; Leroy, P; Mikkelsen, IM; Mortensen, B; Wellman, M | 1 |
| Chao, CC; Chou, WY; Huang, YT; Lin-Chao, S; Ma, CM | 1 |
| Barranco, SC; Greaves, BR; Perry, RR; Rasberry, U | 1 |
| Bruno, NA; Rabier, MJ; Slate, DL | 1 |
| Alvarez, MG; Bates, SE; Fojo, AT; Lai, GM; Moscow, JA | 1 |
| Gipp, JJ; McClelland, RA; Mulcahy, RT | 1 |
| Fram, RJ; Robichaud, NJ | 1 |
| Boyce, HW; Chen, LT; Chen, MF; Ying, HS | 1 |
| Inaba, M; Iwata, K; Kubodera, A; Ozawa, S | 1 |
| Gipp, JJ; McClelland, RA; Mulcahy, RT; Panicucci, R; Ublacker, GA | 1 |
| Dikdan, G; Dimaira, MJ; Hu, JJ; Lea, MA; Zirvi, KA | 1 |
| Leith, JT | 1 |
| Arundel, CM; Bliven, SF; Hallows, KT; Leith, JT | 1 |
| Cohen, GM; d'Arcy Doherty, M; Jordan, J | 1 |
| Cordeiro, RF; Savarese, TM | 1 |
| Guichard, M; Lespinasse, F; Malaise, EP | 1 |
31 other study(ies) available for buthionine sulfoximine and Colonic Neoplasms
| Article | Year |
|---|---|
Melatonin Enhances Anti-tumoral Effects of Menadione on Colon Cancer Cells.
Topics: Antioxidants; Buthionine Sulfoximine; Caco-2 Cells; Colonic Neoplasms; Humans; Melatonin; Oxidative Stress; Vitamin K 3 | 2022 |
Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells.
Topics: Adenocarcinoma; Alkenes; Allyl Compounds; Buthionine Sulfoximine; Cell Division; Colonic Neoplasms; Cysteine; Disulfides; Drug Interactions; G2 Phase; Glutathione; HT29 Cells; Humans; Microtubules; Mitosis; Spindle Apparatus; Sulfides | 2008 |
Glutathione modulation reverses the growth-promoting effect of growth factors, improving the 5-fluorouracil antitumour response in WiDr colon cancer cells.
Topics: Buthionine Sulfoximine; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Epidermal Growth Factor; Fluorouracil; Glutathione; Hepatocyte Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Pyrrolidonecarboxylic Acid; Thiazolidines; Vascular Endothelial Growth Factor A | 2009 |
The redox state of the glutathione/glutathione disulfide couple mediates intracellular arginase activation in HCT-116 colon cancer cells.
Topics: Arginase; Buthionine Sulfoximine; Colonic Neoplasms; Diamide; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Glutathione Disulfide; HCT116 Cells; Humans; Oxidants; Oxidation-Reduction; Oxidative Stress; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Glutathione modulators reverse the pro-tumour effect of growth factors enhancing WiDr cell response to chemotherapeutic agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Camptothecin; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Epidermal Growth Factor; Fluorouracil; Glutathione; Hepatocyte Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Pyrrolidonecarboxylic Acid; Thiazolidines; Vascular Endothelial Growth Factor A | 2010 |
Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells.
Topics: Acetylcysteine; Animals; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Colonic Neoplasms; Glutathione; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Oligopeptides; Oxidative Stress; Polyisoprenyl Phosphates; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Simvastatin | 2010 |
Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azathioprine; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Therapy, Combination; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation | 2011 |
Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis.
Topics: Anticarcinogenic Agents; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Colonic Neoplasms; Humans; Hydrogen Sulfide; Isocyanates | 2005 |
Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice.
Topics: Animals; Buthionine Sulfoximine; Colonic Neoplasms; Enzyme Inhibitors; Glutathione; Male; Mice; Mice, Knockout; Tumor Suppressor Protein p53 | 2007 |
Evaluation of methods for measuring cellular glutathione content using flow cytometry.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds; Buthionine Sulfoximine; Carcinoma; Carcinosarcoma; CHO Cells; Colonic Neoplasms; Cricetinae; Ethylmaleimide; Eukaryotic Cells; Evaluation Studies as Topic; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Humans; Maleates; Mammary Neoplasms, Experimental; Methionine Sulfoximine; Mice; o-Phthalaldehyde; Phenylmercury Compounds; Pyrazoles; Species Specificity; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Colonic Neoplasms; Female; Glutathione; Humans; Kidney; Liver; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Mice, Nude; Rats; Rats, Sprague-Dawley; Reference Values; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
Topics: Buthionine Sulfoximine; Colonic Neoplasms; Cysteine; Cytochrome P-450 Enzyme System; DNA, Neoplasm; Drug Interactions; Drug Resistance; Glutathione; Humans; Methionine Sulfoximine; Mitomycin; Mitomycins; Oxidation-Reduction; Sulfhydryl Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro.
Topics: Adenocarcinoma; Animals; Buthionine Sulfoximine; Cisplatin; Colonic Neoplasms; DNA, Neoplasm; Drug Resistance; Glutathione; Methionine Sulfoximine; Methylazoxymethanol Acetate; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Modulation of glutathione level during butyrate-induced differentiation in human colon derived HT-29 cells.
Topics: Alkaline Phosphatase; Buthionine Sulfoximine; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Cell Line; Colon; Colonic Neoplasms; Glutathione; Humans; Kinetics; Time Factors; Tumor Cells, Cultured | 1997 |
Effects of melatonin on proliferation of cancer cell lines.
Topics: Breast Neoplasms; Buthionine Sulfoximine; Cell Division; Cell Survival; Colonic Neoplasms; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Ethacrynic Acid; Female; Glutathione; Humans; Melatonin; Ovarian Neoplasms; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1998 |
Regulation of gamma-glutamyltransferase in cisplatin-resistant and -sensitive colon carcinoma cells after acute cisplatin and oxidative stress exposures.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cisplatin; Colonic Neoplasms; Drug Resistance, Neoplasm; gamma-Glutamyltransferase; Glutathione; Humans; Oxidative Stress; Reactive Oxygen Species; Tumor Cells, Cultured | 2000 |
Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Colonic Neoplasms; Doxorubicin; Drug Resistance; Gene Expression; Glutathione; Glutathione Transferase; HeLa Cells; Humans; Membrane Glycoproteins; Membrane Proteins; Methionine Sulfoximine; Neoplasm Proteins; Phenotype; Sulfhydryl Compounds; Transcription, Genetic; Tumor Cells, Cultured | 1992 |
Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
Topics: Buthionine Sulfoximine; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Glutathione; Humans; In Vitro Techniques; Methionine Sulfoximine; Mitomycin; Tumor Cells, Cultured | 1992 |
Multifactorial resistance in LS174T human colon carcinoma cells selected with doxorubicin.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Division; Cell Line; Colonic Neoplasms; Doxorubicin; Drug Resistance; Flow Cytometry; Genetic Variation; Humans; Membrane Glycoproteins; Methionine Sulfoximine; Neoplasm Proteins | 1991 |
Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Division; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Resistance; Gene Expression; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Humans; Membrane Glycoproteins; Methionine Sulfoximine; RNA, Messenger; Tumor Cells, Cultured; Verapamil | 1991 |
DNA damage induced in HT-29 colon cancer cells by exposure to 1-methyl-2-nitrosoimidazole, a reductive metabolite of 1-methyl-2-nitroimidazole.
Topics: Buthionine Sulfoximine; Colonic Neoplasms; DNA; DNA Damage; DNA, Neoplasm; Endopeptidase K; Humans; Hydrogen-Ion Concentration; Imidazoles; Methionine Sulfoximine; Nitroimidazoles; Nitroso Compounds; Oxidation-Reduction; Serine Endopeptidases; Tumor Cells, Cultured | 1991 |
Schedule dependence of buthionine sulfoximine in reversing resistance to cisplatin.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Transformation, Neoplastic; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; DNA; Drug Resistance; Glutathione; Humans; Methionine Sulfoximine; Tumor Cells, Cultured | 1990 |
Effect of DL-buthionine-S,R-sulfoximine on 1,2-dimethyl-hydrazine-induced colonic tumors in rats.
Topics: 1,2-Dimethylhydrazine; Animals; Bile Acids and Salts; Buthionine Sulfoximine; Carcinogens; Colonic Neoplasms; Dimethylhydrazines; Glutathione; Intestinal Mucosa; Male; Methionine Sulfoximine; Rats; Rats, Inbred Strains | 1990 |
Intracellular glutathione levels in human colon cancer cells naturally resistant to cross-linking agents.
Topics: Antimetabolites; Buthionine Sulfoximine; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; Drug Resistance; Glutathione; Humans; Leukemia; Methionine Sulfoximine; Nimustine; Tumor Cells, Cultured | 1989 |
Cytotoxicity and glutathione depletion by 1-methyl-2-nitrosoimidazole in human colon cancer cells.
Topics: Buthionine Sulfoximine; Cell Survival; Colonic Neoplasms; Glutathione; Humans; Methionine Sulfoximine; Nitroimidazoles; Tumor Cells, Cultured | 1989 |
Influence of pH on the modification of thiols by carbamoylating agents and effects on glutathione levels in normal and neoplastic cells.
Topics: Animals; Buthionine Sulfoximine; Carbamates; Colonic Neoplasms; Cyanates; DNA, Neoplasm; Glutathione; Humans; Hydrogen-Ion Concentration; Kinetics; Liver; Liver Neoplasms, Experimental; Methionine Sulfoximine; Protein Biosynthesis; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Tumor Cells, Cultured | 1989 |
Potentiation of X ray sensitivity by combinations of sodium butyrate and buthionine sulfoximine.
Topics: Buthionine Sulfoximine; Butyrates; Butyric Acid; Cell Line; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Drug Synergism; Humans; In Vitro Techniques; Methionine Sulfoximine; Radiation-Sensitizing Agents | 1988 |
Changes in X-ray sensitivity and glutathione content of human colon tumor cells after exposure to the differentiation-inducing agent sodium butyrate.
Topics: Buthionine Sulfoximine; Butyrates; Butyric Acid; Cell Line; Cell Survival; Colonic Neoplasms; DNA Repair; DNA, Neoplasm; Glutathione; Humans; Methionine Sulfoximine; Radiation Tolerance; Tumor Cells, Cultured | 1988 |
Effects of glutathione depletion on the cytotoxicity of agents toward a human colonic tumour cell line.
Topics: Antimetabolites; Antineoplastic Agents, Phytogenic; Buthionine Sulfoximine; Cell Line; Cell Survival; Colonic Neoplasms; Drug Evaluation, Preclinical; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Naphthols; Naphthoquinones; Sesquiterpenes; Sesquiterpenes, Guaiane; Vitamin K | 1987 |
Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line.
Topics: Buthionine Sulfoximine; Cell Cycle; Cell Line; Cisplatin; Colonic Neoplasms; Cysteine; Dimethylformamide; Dose-Response Relationship, Drug; Formamides; Glutathione; Humans; Methionine Sulfoximine; Solvents | 1986 |
Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
Topics: Adenocarcinoma; Animals; Buthionine Sulfoximine; Cell Line; Colonic Neoplasms; Female; Glutathione; Humans; Melanoma; Methionine Sulfoximine; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms; Radiation Tolerance; Transplantation, Heterologous | 1986 |